Fred E Cohen Insider Trading $ROKA Sorrento Tech, Inc.

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Fred E Cohen.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Fred E Cohen. Fred E Cohen is Director in BIOCRYST PHARMACEUTICALS INC ($BCRX) and Director in GENOMIC HEALTH INC ($GHDX) and Director in FIVE PRIME THERAPEUTICS INC ($FPRX) and Director in CareDx, Inc. ($CDNA) and Director in VERACYTE, INC. ($VCYT) and Director in TANDEM DIABETES CARE INC ($TNDM) and Director in Roka BioScience, Inc. ($ROKA) and Director in Progyny, Inc. ($PGNY) and Director in Intellia Therapeutics, Inc. ($NTLA) and Director in UroGen Pharma Ltd. ($URGN).

Fred E Cohen in Sorrento Tech, Inc.

Trading Symbol: ROKA
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of Fred E Cohen: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 30 2017
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Fred E Cohen in Sorrento Tech, Inc.

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, BCRX, CDNA, FPRX, GHDX, NTLA, PGNY, ROKA, TNDM, URGN, VCYT

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares
Jun 30 2017	ROKA	Roka BioScience, I ...	Cohen Fred E	Director	Option Exercise	A	2.55	3,000	7,650	3,000
Jun 24 2016	ROKA	Roka BioScience, I ...	Cohen Fred E	Director	Option Exercise	A	0.68	30,000	20,400	30,000
Jun 26 2015	ROKA	Roka BioScience, I ...	Cohen Fred E	Director	Option Exercise	A	2.75	15,000	41,250	15,000

Page: 1